{
  "id": "mhgap#risk_safety_ade7ebd8",
  "title_en": "General — Risk Safety",
  "title_vi": "General — Nguy cơ An toàn",
  "text_en": "other 0.56; 95% CI: 0.44 to 0.73 for lamotrigine versus seizure types in these individuals. Gabapentin is not carbamazepine, HR = 0.65; 95% CI: 0.47 to 0.90 for an appropriate medicine in generalized epilepsy levetiracetam versus carbamazepine). Valproic acid and should only be considered in those with focal also has an advantage over carbamazepine in terms onset seizures. of adverse events (HR = 1.96; 95% CI: 1.13 to 3.39). y No systematic review of RCTs comparing these ASMs y Given the risks associated with sodium valproate if with placebo was found. It is considered unethical to prescribed to women and girls who are able to have conduct RCTs comparing standard ASMs, especially children, lamotrigine or levetiracetam should be as monotherapy, with placebo in established used as first-line treatment in this population. epilepsy as epilepsy should be treated to decrease y For focal onset seizures there is high-certainty morbidity and premature mortality. evidence to suggest that carbamazepine performs y Both levetiracetam and sodium valproate are better than gabapentin in terms of seizure effective against all types of seizures, and hence may remission (HR = 1.29; 95% CI: 1.06 to 1.57), and that be ASMs of choice when the type of seizure/epilepsy carbamazepine has similar performance to other syndrome is not clear. ASMs, including levetiracetam and lamotrigine. y All ASMs are associated with adverse effects. y For focal onset seizures, levetiracetam and Phenobarbital is associated with a higher risk of lamotrigine perform significantly better than short- and long-term tolerability problems. carbamazepine in terms of adverse events (HR = 0.56; 95% CI: 0.44 to 0.73 for lamotrigine versus y When taken during pregnancy, sodium valproate carbamazepine, HR = 0.65; 95% CI: 0.47 to 0.90 is associated with a markedly higher risk of fetal for levetiracetam vs carbamazepine). Given their malformations. Sodium valproate (valproic acid) better side-effect profile and similar efficacy to has also been associated with hepatic side- carbamazepine, lamotrigine and levetiracetam are effects, in terms of raised transaminases and now recommended for focal epilepsy. elevated ammonia levels. Sodium valproate is contraindicated in individuals with liver disease. Remarks y Phenytoin, despite being used as a first-line drug in y As ASM choice depends on seizure semiology, some places, has a problematic pharmacokinetic outcomes are reported separately for focal onset profile. Phenytoin has associated risks of arrhythmia seizures (focal seizures with or without awareness, and hypotension and can be difficult to administer in focal to bilateral tonic-clonic seizures) and adults with comorbid cardiac conditions. generalized onset tonic-clonic seizures (with or y Most trials excluded women known to be without other generalized seizure types such as pregnant. Seizures in pregnant women can myoclonus or absence seizures). be due to eclampsia, which requires different treatment strategies. 81",
  "gloss_vi": "Other 0.56; 95% ci: 0.44 to 0.73 for lamotrigine versus seizure types in these individuals. gabapentin is not carbamazepine, hr = 0.65; 95% ci: 0.47 to 0.90 for an appropriate medicine in generalized epilepsy levetiracet...",
  "source": "WHO mhGAP-IG 2023",
  "url": "https://www.who.int/",
  "lang": "en",
  "axes": {
    "type": [
      "clinical",
      "everyday"
    ],
    "condition": [
      "General"
    ],
    "clinical_section": [
      "risk_safety",
      "do_not_do",
      "management"
    ],
    "life_topics": [
      "stress"
    ],
    "advice_section": [],
    "audience": [],
    "risk_band": "low"
  },
  "index_text": "General — Risk Safety General — Nguy cơ An toàn other 0.56; 95% CI: 0.44 to 0.73 for lamotrigine versus seizure types in these individuals. Gabapentin is not carbamazepine, HR = 0.65; 95% CI: 0.47 to 0.90 for an appropriate medicine in generalized epilepsy levetiracetam versus carbamazepine). Valproic acid and should only be considered in those with focal also has an advantage over carbamazepine in terms onset seizures. of adverse events (HR = 1.96; 95% CI: 1.13 to 3.39). y No systematic review of RCTs comparing these ASMs y Given the risks associated with sodium valproate if with placebo was found. It is considered unethical to prescribed to women and girls who are able to have conduct RCTs comparing standard ASMs, especially children, lamotrigine or levetiracetam should be as monotherapy, with placebo in established used as first-line treatment in this population. epilepsy as epilepsy should be treated to decrease y For focal onset seizures there is high-certainty morbidity and premature mortality. evidence to suggest that carbamazepine performs y Both levetiracetam and sodium valproate are better than gabapentin in terms of seizure effective against all types of seizures, and hence may remission (HR = 1.29; 95% CI: 1.06 to 1.57), and that be ASMs of choice when the type of seizure/epilepsy carbamazepine has similar performance to other syndrome is not clear. ASMs, including levetiracetam and lamotrigine. y All ASMs are associated with adverse effects. y For focal onset seizures, levetiracetam and Phenobarbital is associated with a higher risk of lamotrigine perform significantly better than short- and long-term tolerability problems. carbamazepine in terms of adverse events (HR = 0.56; 95% CI: 0.44 to 0.73 for lamotrigine versus y When taken during pregnancy, sodium valproate carbamazepine, HR = 0.65; 95% CI: 0.47 to 0.90 is associated with a markedly higher risk of fetal for levetiracetam vs carbamazepine). Given their malformations. Sodium valproate (valproic acid) better side-effect profile and similar efficacy to has also been associated with hepatic side- carbamazepine, lamotrigine and levetiracetam are effects, in terms of raised transaminases and now recommended for focal epilepsy. elevated ammonia levels. Sodium valproate is contraindicated in individuals with liver disease. Remarks y Phenytoin, despite being used as a first-line drug in y As ASM choice depends on seizure semiology, some places, has a problematic pharmacokinetic outcomes are reported separately for focal onset profile. Phenytoin has associated risks of arrhythmia seizures (focal seizures with or without awareness, and hypotension and can be difficult to administer in focal to bilateral tonic-clonic seizures) and adults with comorbid cardiac conditions. generalized onset tonic-clonic seizures (with or y Most trials excluded women known to be without other generalized seizure types such as pregnant. Seizures in pregnant women can myoclonus or absence seizures). be due to eclampsia, which requires different treatment strategies. 81 Other 0.56; 95% ci: 0.44 to 0.73 for lamotrigine versus seizure types in these individuals. gabapentin is not carbamazepine, hr = 0.65; 95% ci: 0.47 to 0.90 for an appropriate medicine in generalized epilepsy levetiracet..."
}